Skip to main content

Context Therapeutics Inc.

CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001842952

No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.

Members of Congress who traded CNTX

No member of Congress has reported a trade in Context Therapeutics Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.